From DNA to Drugs: How AI Is Rewriting Human Biology

DNA is just another language.

In Episode 32 of Built This Week, we sit down with Dov Gertz, founder of Converge Bio, to explore how generative AI is transforming drug discovery.

Every human can be represented as 3.2 billion nucleotides built from four letters: A, C, G, and T. If computers run on zeros and ones, we run on biological code.

Converge Bio is training frontier foundation models on DNA, RNA, proteins, and small molecules — helping biotech and pharma companies design better drugs, faster and cheaper.

We also demo a retro-inspired “Cell Defense Arena” game built for Converge to use at conferences.

Then we pivot into AI infrastructure and agent workflows:

The GPU bottleneck and pharma’s growing demand for compute
Why molecular AI is 5 to 10 years behind text models
How AI could reduce drug timelines from 10 years to 6 to 8
Why cancer and autoimmune diseases may benefit first
The limits of FDA regulation in shortening approval cycles
OpenClaw, multi-agent systems, and infinite AI teams
Cloud versus on prem in the era of foundation models

The big takeaway:

Chatbots are impressive.
But AI applied to biology could extend human life.

If you work in biotech, pharma, AI research, or frontier infrastructure — this episode is for you.

New episodes every Friday.

⏱ TIMESTAMPS

(0:00) DNA as code: 3.2 billion nucleotides
(0:32) Welcome to Episode 32
(1:00) Meet Dov Gertz and Converge Bio
(2:02) Demo: Cell Defense Arena game
(3:25) Converge Bio’s $33M raise and mission
(4:05) Foundation models for molecular data
(5:00) Turning DNA, RNA, and proteins into machine-readable text
(6:02) How transformers apply to biology
(7:03) 400x more DNA than text on the internet
(8:02) Who Converge’s customers are
(9:21) Faster, cheaper, better drug discovery
(10:39) The three bottlenecks: data, architecture, compute
(12:02) The future of personalized medicine
(13:02) Which diseases benefit first: cancer, diabetes, autoimmune
(14:00) Regulatory realities and clinical trial timelines
(16:30) Will AI shorten drug approval cycles?
(17:01) NVIDIA, GPUs, and scaling molecular AI
(18:30) Pharma as a new AI infrastructure consumer
(19:13) Hard pivot: OpenClaw and agentic AI
(21:26) Managing teams of AI agents
(22:20) Cloud versus on prem debate
(25:02) Why developers must adapt weekly
(29:26) Closing thoughts and where to find Converge Bio

🔗 LINKS

Converge Bio
https://converge-bio.com

Built This Week
New episodes every Friday
https://builtthisweek.com

Jordan Metzner
https://x.com/mrjmetz

Sam Nadler
https://x.com/Gravino05

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(55)

Nobody Takes Notes Anymore. 5 Million People Let AI Do It Instead.

This week we sat down with Rob Williams, co-founder and CTO of Read AI, to dig into what 5 million monthly active users actually looks like at the product and infrastructure level. Most people know Re...

9 Okt 22min

He Ran a Rocket Launch Company. Now He Is Building Autocomplete for Hardware Design.

He Ran a Rocket Launch Company. Now He Is Building Autocomplete for Hardware Design.This week we sat down with Sohrab Haghighat, CEO and co-founder of Hestus, to demo the AI layer that sits on top of ...

2 Okt 17min

She Sold Her First AI Company to Google in 2009. Now She Is Fixing How Teams Work.

This week we sat down with Jennifer Dulski, CEO and founder of Rising Team, to demo the AI leadership platform that acts as a personal trainer for your effectiveness at work. Jen spent 10 years at Yah...

21 Sep 21min

It Ships While You Sleep. The AI Agent OS a Former Google Engineer Built After Leaving Google.

This week we sat down with David Petrou, CEO of Continua, to demo Wheely — an agent development operating system built for developers running multiple AI coding agents who are hitting the wall of ment...

4 Sep 26min

Physics Simulation for Chip Design Used to Take Days. This AI Does It in Seconds.

This week we sat down with Hardik Kabaria, co-founder and CEO of Vinci, to demo the AI platform making physics simulation accessible to any engineer building hardware. A chip tape-out used to cost mil...

10 Jul 30min

A Ten Minute Phone Video Replaces Hours of Home Inspections. We Demo the AI Doing It.

This week we sit down with Zach Rattner, CTO and co-founder of Yembo, to demo the computer vision platform that turns a ten minute phone walkthrough into a full home inventory, 3D model, and floor pla...

3 Jul 16min

The Code Running Your Plane Was Written Decades Ago. This Startup Proves It Still Works.

This week we sit down with Ryan Aytay, President and COO of Code Metal, to dig into one of the most underestimated problems in tech — the legacy code running mission critical infrastructure across aer...

26 Jun 24min

AI Agents Doing Commercial Real Estate Due Diligence in Minutes. We Demo It Live.

This week on Built This Week we sit down with Jackson, co-founder of Realm AI, to demo the platform replacing months of manual due diligence with AI agents that find, compile, and cite every piece of ...

19 Jun 24min